AxoGen, Inc. CEO Karen Zaderej To Discuss AxoGen’s Growth, Nerve Injury And New Options For Nerve Repair On "The Big Biz Show"

Interview Airs March 20, 2015, Hosted by Bob "Sully" Sullivan, 10:35am ET/7:35am PT/9:35am CT

ALACHUA, FL, March 19, 2015 – AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company dedicated to peripheral nerve repair, announced today that Chief Executive Officer Karen Zaderej will be interviewed on BizTalkRadio’s “The Big Biz Show” hosted by Bob “Sully” Sullivan. In this exclusive interview, Ms. Zaderej will discuss the Company’s growth and large market opportunity for its portfolio of peripheral nerve repair solutions which offer alternatives to patients who require surgical repair of peripheral nerves due to injury and trauma. Shareholders, analysts, industry professionals and all interested parties are encouraged to listen live via Clear Channel's nationally syndicated iHeart Radio stream.

Date: Friday, March 20, 2015
Start Time: 10:35am ET | 7:35am PT | 9:35am CT (U.S.)
Network: BizTalkRadio
Show: The Big Biz Show
Host: Bob “Sully” Sullivan
Live Stream: http://player.warpradio.com/BizTalkRadio/index.php

About The Big Biz Show

Sully is a Nationally Syndicated Radio/TV Personality who has something to say about all things in the World of Business! Monday - Friday 9am - 12pm PT / 12pm - 3pm ET. "The Big Biz Show" is named in the TOP TEN Financial Radio Talk Shows by TALKERS Magazine.

About BizTalkRadio

BizTalkRadio is the home for your business. Whether you're an entrepreneur, small business owner or just managing your family's assets, BizTalkRadio can help. Small business generated 64% of all new jobs in the last decade. There are more than 30 million small businesses and 15 million home-based companies in the United States. BizTalkRadio is the only network committed to original, educational and compelling programming about real people succeeding in business.

About AxoGen, Inc.

AxoGen (NASDAQ: AXGN) is a leading medical technology company dedicated to peripheral nerve repair. AxoGen’s portfolio of regenerative medicine products is available in the United States, Canada and several other countries and includes Avance® Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site, AxoGuard® Nerve Connector, a porcine submucosa extracellular matrix (“ECM”) coaptation aid for tensionless repair of severed nerves, and AxoGuard® Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments.

Avance® Nerve Graft is processed in the United States by AxoGen. AxoGuard® Nerve Connector and AxoGuard® Nerve Protector are manufactured in the United States by Cook Biotech Incorporated, and are distributed worldwide exclusively by AxoGen. AxoGen maintains its corporate offices in Alachua, Florida and is the parent of its wholly owned operating subsidiary, AxoGen Corporation.

For more information about AxoGen or to sign up for our news alerts, please visit www.AxoGenInc.com.

Company Contact:
AxoGen, Inc.
Lee Robert “Bob” Johnston
Chief Financial Officer
386.462.6856
InvestorRelations@AxoGenInc.com

Help employers find you! Check out all the jobs and post your resume.

Back to news